Washington, D.C., March 20, 2014—The Council for Responsible Nutrition (CRN) and VIRGO Publishing today announced details for an industry-wide webinar focusing on three “hot button” regulatory initiatives including: the U.S. Food and Drug Administration’s (FDA) guidance on investigational new drug (IND) applications; new proposed rules under the Food Safety Modernization Act (FSMA); and the Federal Trade Commission’s (FTC) views on claims substantiation and more. The two-hour webinar, entitled, “Spring Regulatory Roundup: INDs, FSMA, FTC,” will take place Wednesday, April 23, beginning at 2 p.m. EDT
“What you don’t know about these regulatory issues can hurt your company,” said Rend Al-Mondhiry, regulatory counsel, CRN, who will moderate the webinar. “While many in the industry may be generally aware of these acronyms—IND, FSMA and, of course, FTC—it’s our goal to be sure that everyone in the industry gets up to speed on the latest regulatory initiatives behind these acronyms. This webinar will help.”
Webinar participants will gain a better understanding of these current regulatory hot topics from carefully selected experts who’ll share their professional insights and help arm participants with the knowledge to face imminent regulatory changes and opportunities, and the ability to follow the law. Presenters include: Richard Cleland, assistant director, Division of Advertising Practices, FTC; Shelly Garg, associate, FDA Practice Group, Sandler, Travis & Rosenberg; Jennifer McEntire, Ph.D., vice president and chief science officer, The Acheson Group; and Jennifer Schwartz, associate, Covington & Burling.
The registration fee—$149 for CRN members and $199 for non-members—is a per registration site fee, so multiple people may participate in the webinar from a single site, such as a company’s conference room. This fee also includes unlimited access to the on-demand recording of the webinar for 90 days. Additional details and registration information are available at: www.crnusa.org/regroundup.